Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Maureen E. Stefaniak"'
Autor:
Joseph T. Bruder, Elena Semenova, Ping Chen, Keith Limbach, Noelle B. Patterson, Maureen E. Stefaniak, Svetlana Konovalova, Charlie Thomas, Melissa Hamilton, C. Richter King, Thomas L. Richie, Denise L. Doolan
Publikováno v:
PLoS ONE, Vol 7, Iss 5 (2012)
Externí odkaz:
https://doaj.org/article/399a97eb8c624818ac3aba0381f78548
Autor:
Gary R. Matyas, Fanta Kalle, Carl R. Alving, Timothy W. Phares, Maureen E. Stefaniak, Keith Limbach, Christopher J. Genito, Elke S. Bergmann-Leitner, Noelle B. Patterson, Zoltan Beck, Sheetij Dutta, Norman C. Waters
Publikováno v:
Vaccine. 35:3865-3874
Malaria caused by Plasmodium falciparum continues to threaten millions of people living in the tropical parts of the world. A vaccine that confers sterile and life-long protection remains elusive despite more than 30years of effort and resources inve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f64734b1370caafab4bcbde0a8ccd00
https://doi.org/10.1016/j.vaccine.2017.05.070
https://doi.org/10.1016/j.vaccine.2017.05.070
Autor:
Ping Chen, Martha Sedegah, Maureen E. Stefaniak, Svetlana Krepkiy, Damodar Ettyreddy, John M. Vulule, Keith Limbach, Shaojie Weng, Thomas L. Richie, Arnel Belmonte, Noelle B. Patterson, Kalpana Gowda, Grant Liao, Douglas E. Brough, Joseph T. Bruder, Greg Ekberg, Holly Torano, Esteban Abot, Ann M. Moormann, Eileen Villasante, Sharvari Sonawane, Michael R. Hollingdale
Publikováno v:
Malaria Journal
Malaria Journal, Vol 16, Iss 1, Pp 1-12 (2017)
Malaria Journal, Vol 16, Iss 1, Pp 1-12 (2017)
Background A DNA-human Ad5 (HuAd5) prime-boost malaria vaccine has been shown to protect volunteers against a controlled human malaria infection. The potency of this vaccine, however, appeared to be affected by the presence of pre-existing immunity a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b73b98c607784843822d2590bb4d4eb7
https://pubmed.ncbi.nlm.nih.gov/28673287
https://pubmed.ncbi.nlm.nih.gov/28673287
Autor:
Carlota Dobaño, Maureen E. Stefaniak, Martha Sedegah, Norma L. Graber, Denise L. Doolan, Joseph J. Campo, Gary T. Brice, Daniel J. Carucci
Publikováno v:
Microbes and Infection. 9:1439-1446
Effective vaccines against infectious diseases and biological warfare agents remain an urgent public health priority. Studies have characterized the differentiation of effector and memory T cells and identified a subset of T cells capable of conferri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcf23edd23d216aa3900952d553f2a19
https://doi.org/10.1016/j.micinf.2007.07.009
https://doi.org/10.1016/j.micinf.2007.07.009
Autor:
Charlie Thomas, Svetlana Konovalova, Ping Chen, Joseph T. Bruder, C. Richter King, Elena Semenova, Denise L. Doolan, Maureen E. Stefaniak, Keith Limbach, Thomas L. Richie, Noelle B. Patterson, Melissa Hamilton
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e33920 (2012)
PLoS ONE
PLoS ONE
The development of an effective malaria vaccine is a high global health priority. Vaccine vectors based on adenovirus type 5 are capable of generating robust and protective T cell and antibody responses in animal models and are currently being evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::993cf0bca0181e701ea8021ba46f87e3
http://europepmc.org/articles/PMC3320611?pdf=render
http://europepmc.org/articles/PMC3320611?pdf=render
Autor:
Ping Chen, Joseph T. Bruder, Svetlana Konovalova, Sheng Li, Carole A. Long, Damodar Ettyreddy, Keith Limbach, Noelle B. Patterson, Filip Dubovsky, Maureen E. Stefaniak, Denise L. Doolan, Joseph J. Campo, C. Richter King, Thomas L. Richie
Publikováno v:
Vaccine. 28(18)
An effective malaria vaccine remains a global health priority. Recombinant adenoviruses are a promising vaccine platform, and Plasmodium falciparum apical membrane antigen 1 (AMA1) and merozoite surface protein 1-42 (MSP1(42)) are leading blood stage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e606109a1bea3f5d7242e4d3961ad7a
https://pubmed.ncbi.nlm.nih.gov/20188680
https://pubmed.ncbi.nlm.nih.gov/20188680
Autor:
Maureen E. Stefaniak, Carlota Dobaño, David P. Regis, Daniel J. Carucci, Denise L. Doolan, Joseph J. Campo, Xiaowu Liang, Norma L. Graber, Philip L. Felgner, Huaping He, Paola Quiñones-Olson, David A. Roth
Publikováno v:
Molecular and biochemical parasitology. 158(1)
We have evaluated a technology called transcriptionally active PCR (TAP) for high throughput identification and prioritization of novel target antigens from genomic sequence data using the Plasmodium parasite, the causative agent of malaria, as a mod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad844d2a2a7afc6c99ca2a9dd35542ba
https://pubmed.ncbi.nlm.nih.gov/18164079
https://pubmed.ncbi.nlm.nih.gov/18164079
Autor:
Maureen E. Stefaniak, Svetlana Konovalova, Sheng Li, Richter C. King, Ping Chen, Joseph T. Bruder, Denise L. Doolan, Joseph J. Campo, Noelle B. Patterson, Keith Limbach
Publikováno v:
Molecular Therapy. 13:S8-S9
Malaria is the most devastating parasitic disease affecting humans. Each year there are 300-500 million new infections and 1-3 million deaths, primarily of children in sub-Saharan Africa. The feasibility of a malaria vaccine is supported by the demon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b00b5e976a9c619e8e1d750a295a712b
Autor:
Mcvey Duncan L, C.R. King, Maureen E. Stefaniak, Joseph T. Bruder, Damodar Ettyreddy, Joseph J. Campo, Denise L. Doolan, Fe Maria Baraceros, Noelle B. Patterson
Publikováno v:
Molecular Therapy. 11:S382
Malaria is the most devastating parasitic disease affecting humans. Each year 300-500 million people become infected with the parasite and more than 1.5 million people, primarily children, die of the disease. The feasibility of a malaria vaccine is s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::346f6c168c9885f112a4a54f1432c714
https://doi.org/10.1016/j.ymthe.2005.07.536
https://doi.org/10.1016/j.ymthe.2005.07.536
Autor:
Joseph T Bruder, Elena Semenova, Ping Chen, Keith Limbach, Noelle B Patterson, Maureen E Stefaniak, Svetlana Konovalova, Charlie Thomas, Melissa Hamilton, C Richter King, Thomas L Richie, Denise L Doolan
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e33920 (2012)
The development of an effective malaria vaccine is a high global health priority. Vaccine vectors based on adenovirus type 5 are capable of generating robust and protective T cell and antibody responses in animal models and are currently being evalua
Externí odkaz:
https://doaj.org/article/a5d21dfeacc34529810ff1df47ca014f